Clinical Trial: Dual Algorithm Post Market Clinical Study

Study Status: Enrolling by invitation
Recruit Status: Enrolling by invitation
Study Type: Observational




Official Title: Evaluation of the MP Diagnostics HTLV Blot 2.4

Brief Summary: The purpose of this study is to assess the validity and reproducibility of the MP Diagnostics HTLV Blot 2.4 in blood specimens testing repeat reactive (RR) on the first FDA licensed screening assay (Abbott Prism) and non-reactive (NR) on the second FDA licensed screening assay (Avioq ELISA).